Reduction of excitotoxicity-induced brain damage by the competitive NMDA antagonist CCP 40116: A longitudinal study using diffusion-weighted imaging

Neuroscience Letters

Volumn 213, Issue 3, 1996, Pages 209-212

  Laurent, Didier ^a   Eis, Manfred ^a   Sauer, Dirk ^a   Theilkaes, Willi ^a   Allegrini, Peter R ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

CGP 40116; Diffusion weighted imaging (DWI); Excitotoxicity; Magnetic resonance imaging; N Methyl D aspartate antagonist; Quinolinic acid; Rat brain

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; EXCITOTOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

EID: 0030576574     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12857-3     Document Type: Article

References (25)

1. [1] Albers, G.W., Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia, Clin. Neuropharmacol., 13 (1990) 177-197.
2. [2] Allegrini, P.R. and Sauer, D., Application of magnetic resonance imaging to the measurement of neurodegeneration in the rat brain: MRI data correlate strongly with histology and enzymatic analysis, Magn. Reson. Imaging, 10 (1992) 773-778.
3. [3] Bakker, M.H. and Foster, A.C., An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo, Neuroscience, 42 (1991) 387-395.
4. [4] Benveniste, H., Hedlund, L.W. and Johnson, G.A., Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy, Stroke, 23 (1992) 746-754.
5. [5] Fedele, E. and Foster, A.C., An evaluation of the role of extracellular amino acids in the delayed neurodegeneration induced by quinolinic acid in the rat striatum, Neuroscience, 52 (1993) 911-917.
6. [6] Foster, A.C., Gill, R. and Woodruf, G.N., Neuroprotective effects of MK 801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation, J. Neurosci., 8 (1988) 4745-4754.
7. [7] Hossmann, K.-A. and Hoehn-Berlage, M., Diffusion and perfusion MR imaging of cerebral ischemia, Cerebrovasc. Brain Metab. Rev., 7 (1995) 187-217.
8. [8] Ikonomidou, C., Mosinger, J.L., Salles, K.S., Labruyere, J. and Olney, J.W., Sensitivity of the developing rat brain to hypobaric/ ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity, J. Neurosci., 9 (1989) 2809-2818.
9. [9] King, M.D., van Bruggen, N., Ahier, R.G., Cremer, J.E., Hajnal, J.V., Williams, S.R. and Doran, M., Diffusion-weighted imaging of kainic acid lesions in the rat brain, MRM, 20 (1991) 158-164.
10. [10] Knight, R.A., Dereski, M.O., Helpern, J.A., Ordidge, R.J. and Chopp, M., Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats [published erratum appears in Stroke (1994) 25(9) 1887], Stroke, 25 (1994) 1252-1261.
11. [11] Lin, T.-N., Wu, Y.Y., Khan, M. and Hsu, C.Y., Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats, Stroke, 24 (1993) 117-121.
12. [12] McCulloch, J., Bullock, R. and Teasdale, G.M., Excitatory amino acid antagonists: opportunities for the treatment of ischaemic brain damage in man. In B.S. Meldrum (Ed.), Excitatory Amino Acids Antagonists, Blackwell Scientific, Oxford, 1991, pp. 287-326.
13. [13] McDermott, A.B., Mayer, M.L., Westbrook, G.L., Smith, S.J. and Baker, J.L., NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons, Nature, 321 (1986) 519-522.
14. [14] Meldrum, B.S., Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission, Cerebrovasc. Brain Metab. Rev., 2 (1990) 27-57.
15. [15] Mintorovitch, J., Moseley, M.E., Chileuitt, L., Shimizu, H., Cohen, Y. and Weinstein, P.R., Comparison of diffusion-and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats, MRM, 18 (1991) 39-50.
16. [16] Nakada, T. and Matsuzawa, H., Three-dimensional anisotropy contrast magnetic resonance imaging of the rat nervous system: MR axonography, Neurosci. Res., 22 (1995) 389-398.
17. [17] Olney, J.W., Neurotoxicity of excitatory amino acids. In E.G. McGeer, J.W. Olney and P.L. McGeer (Eds.), Kainic Acid as a Tool in Neurobiology, Raven PressNew York, 1978, pp. 95-121.
18. [18] Olney, J.W., Ho, O.L. and Rhee, V., Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system, Exp. Brain Res., 14 (1971) 61-76.
19. [19] Sauer, D., Allegrini, P.R., Thedinga, K.H., Massieu, L., Amacker, H. and Fagg, G.E., Evaluation of quinolinic acid induced excitotoxic neurodegeneration in rat striatum by quantitative magnetic resonance imaging in vivo, J. Neurosci. Methods, 42 (1992) 69-74.
20. [20] Schwarcz, R., Whetsell, W.O. and Mangano, R.E.M., Quinolinic acid: endogenous metabolite that can produce axon sparing lesions in rat brain, Science, 219 (1983) 316-318.
21. [21] Stejskal, E.O. and Tanner, J.E., Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient, J. Chem. Phys., 42 (1965) 282-292.
22. [22] van Bruggen, N., Roberts, T.P. and Cremer, J.E., The application of magnetic resonance imaging to the study of experimental cerebral ischaemia, Cerebrovasc. Brain Metab. Rev., 6 (1994) 180-210.
23. [23] van Lockeren Campagne, M., Verheul, J.B., Nicolay, K. and Balázs, R., Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology, J. Cereb. Blood Flow Metab., 14 (1994) 1011-1023.
24. [24] Van Zijl, P.C., Moonen, C.T., Faustino, P., Pekar, J., Kaplan, O. and Cohen, J.S., Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy, Proc. Natl. Acad. Sci. USA, 88 (1991) 3228-3232.
25. 1H nuclear magnetic resonance imaging, Brain Res., 618 (1993) 203-212.